Results

Total Results: 3,151 records

Showing results for "disease".

421. Considering the Range of Decision-Relevant Effects (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
     June 01, 2012 - screening for reportable diseases such as syphilis or HIV. … An individual diagnosed with coronary disease might alter his or her lifestyle to reduce disease progression … Although the prognoses for some diseases are minimally modifiable with current treatments, most prognostic … asymptomatic individuals or individuals with unrecognized symptoms to detect as many different types of diseases … Screening tests should not be employed to detect as many diseases as possible, but rather only when there

422. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
     June 06, 2011 - cause of mortality for women in the United States.1 Coronary heart disease—which includes coronary … Current diagnostic concepts to detect coronary artery disease in women. … Non-invasive imaging for coronary artery disease. Technology Assessment. … [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR … "coronary heart disease"[tiab]) + Comparisons: 6 groups of terms.

423. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-chronic-conditions-interventions_research-protocol.pdf
     September 21, 2011 - In 2010, cardiovascular, lung, and blood diseases were projected to cost $486 billion in health care … mortality ○ Disease-related morbidity ○ Disease-related functional status ○ Mental health–related … mortality ○ Disease-related morbidity ○ Disease-related functional status ○ General health–related … Morbidity & mortality: 2009 chart book on cardiovascular, lung, and blood diseases. … Atlanta, GA: Centers for Disease Control and Prevention; 2008.

424. Disposition of Comments Report for Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
     December 11, 2012 - For key questions 3 and 4 patients were excluded if extrahepatic disease was present. … It is estimated that only about 25% of patients truly present with metastatic disease. … who can only have their entire disease burden treated by some form of embolotherapy. … was not described as liver-dominant disease or minimally extra-hepatic disease. … for the vast majority individuals over the course of their disease.

425. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - Comparative Effectiveness Review Number 58 Noninvasive Technologies for the Diagnosis of Coronary Artery Disease … in Women Executive Summary Background Cardiovascular disease is the leading cause of mortality for … Current diagnostic concepts to detect coronary artery disease in women. … Non-invasive imaging for coronary artery disease. Technology Assessment. … Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women.

426. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
     September 27, 2012 - Hepatic metastasis from colorectal cancer is defined as resectable when it is anticipated that disease … The volume of disease in these patients is small, either in terms of lesion size or number of lesions … Patients whose treatment has failed or whose disease progressed while receiving systemic chemotherapy … These patients generally have large–volume, diffuse disease and are not candidates for ablation but … Intermediate outcomes that impact overall survival include time to progression of disease and tumor

427. Microsoft Word - finbody.doc (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
     January 01, 2007 - diffuse atherosclerotic vascular diseases.5,6 In the United States 12 to 14 percent of new patients … group of patients with unilateral disease. … A history or markers of some cardiovascular diseases were associated with increased mortality, poor … Human Services/National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases … Renal angioplasty for renovascular disease: a reappraisal.

428. Methods Guide for Medical Test Reviews Chapter 6 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
     July 01, 2012 - Spectrum of disease in practice and in studies. Source of population not described. … Exclude if no disease outcomes and outcomes key to understanding intended use case. … Spectrum Effect The severity or type of disease may effect the accuracy of the test. … or fetal anatomic survey, and MRI for detection of spinal conditions or joint disease. … Prevalence is inexorably tied to disease definitions that may also change over time.

429. Health Topics | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics
     Bladder Diseases Doctors diagnose bladder diseases using different tests. … Bone Marrow Diseases Bone marrow is the spongy tissue inside some of your bones, such as your hip and … Colonic Diseases Your colon, also known as the large intestine, is part of your digestive system. … Degenerative Nerve Diseases Degenerative nerve diseases affect many of your body's activities, such as … Lipid Metabolism Disorders Lipid metabolism disorders, such as Gaucher disease and Tay-Sachs disease,

430. S143 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s143.pdf
     October 01, 2007 - medical service from a provider with a diagnosis coded according to International Classification of Diseases … in the past year 0.96 0.54 �0.01 0.74 0.83 0.12 Mean no. cardiovascular disease-related diagnoses … 0.25 0.17 �0.01 0.21 0.23 0.21 Mean no. cardiovascular disease-related hospitalizations in the past … Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. … The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.

431. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease … Of Internal Medicine BMJ JAMA Lancet New England Journal Of Medicine Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease

432. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease … Of Internal Medicine BMJ JAMA Lancet New England Journal Of Medicine Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease

433. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
     December 15, 2010 - Ischemic heart disease CVD surgery and procedures Arrhythmias Quality of life Other heart disease … o Congestive heart failure o Valvular disease • Cerebrovascular disease o All stroke o Hemorrhagic … Use of complementary therapies in patients with cardiovascular disease. … Use of herbal products and potential interactions in patients with cardiovascular diseases. … Herbal medicine for the treatment of cardiovascular disease: clinical considerations.

434. Liver-Cancer-Therapy Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
     May 01, 2013 - to differentiate between patients with BCLC stage A and B liver disease across publications. … This was calculated from the date of disease response to treatment to the date of disease progression … Subgroups of interest include age, sex, HCC stage, disease etiology, lesion size, and multifocal disease … • No studies presented subgroup analyses on age, sex, disease etiology, or HCC stage. … RFA to PEI/PAI: disease etiology Insufficient None of the 3 RCTs reported subgroup analysis by disease

435. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
     January 01, 2008 - 09 1 Results of Topic Selection Process & Next Steps  Clostridium difficile-associated disease … in-hospital infection control, appropriate antibiotic prescribing, and effective treatment of existing disease … Clostridium difficile-associated disease (CDAD) Nomination Summary Document http://effectivehealthcare.ahrq.gov

436. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - in this field focuses on drugs and biologics for irritable bowel syndrome and inflammatory bowel diseases … Bethesda (MD): National Digestive Diseases Information Clearinghouse (NDDIC); 2007 May [updated … National Digestive Diseases Information Clearinghouse (NDDIC). Short bowel syndrome. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National … Teduglutide, a glucagon-like peptide- 2 analog for the treatment of gastrointestinal diseases, including

437. Surgery | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/surgery?page=4
     May 02, 2011 - 2011 Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease … 2011 Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease … January 24, 2011 Comparative Effectiveness of Treatment Strategies for Women With Coronary Artery Disease … Comparison of Percutaneous Coronary Interventions With Bypass Graft Surgery in Nonacute Coronary Artery Disease … September 1, 2010 Comparative Effectiveness of Pharmacologic Therapies for the Management of Crohn’s Disease

438. Eye Care | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/eye-care
     But some eye diseases can lead to vision loss , so it is important to identify and treat eye diseases … These diseases can lead to some eye or vision problems. … Some eye diseases are inherited, so it is important to find out whether anyone in your family has had … This can help you determine if you are at higher risk of developing an eye disease. … As you get older, you are at higher risk of developing age-related eye diseases and conditions.

439. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 13: Pulmonary Disease … Slowing disease progression could lead to improved quality of life and reduced costs. … None of these approaches halts disease progression. … exacerbations, which may slow disease progression. … Slowed disease progression could lead to improved patient quality of life and reduced costs.

440. Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/polyunsaturated-fatty/protocol
     November 01, 2024 - wasted participants Participants who are pre- or post-bariatric surgery Participants with other chronic diseases … (e.g., cancer, gastrointestinal disease, rheumatic disease, chronic kidney disease, neurologic diseases … CVD (e.g., history of myocardial infarction, angina, stroke, arrhythmia), including congenital heart diseases … Substitution of Dairy Products and Risk of Death and Cardiometabolic Diseases: A Systematic Review and … Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.